Skip to main content
Equibles

VIMTALABS · Vimta Labs Limited

Use VIMTALABS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VIMTALABS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
498.90 INR -6.70 (-1.33%) At close · Nov 13
Rebalance outlook locked
Market Cap
22.30B INR
Shares
44.70M
Volume · Nov 13 53.3K Avg daily vol (3M) 168.9K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close498.90 INR Open510.00 INR Day492.50–510.00 INR 52W close380.70–661.75 INR Avg vol 30d100K Last earningsOct 30, 2026 DataJun 2025–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Jun 13, 2025; bars on opposite sides are not compared.

Latest documents

2026
Oct 30
Earnings call
Q2 FY '27 total income rises 9.9%, EBITDA margin reaches 35.5%

Vimta Labs Limited reported Q2 FY '27 total income of INR1,149 million, up 9.9% year-on-year, EBITDA of INR408 million and a 35.5% margin. Biologics began generating revenue, while CRADS and clinical research are expected to improve in Q3 and Q4.

5 source passages
Total income for Q2 FY '27 stood at INR1,149 million as compared to INR1,045 million in Q2 FY '26, up by 9.9% year-on-year. EBITDA stood at INR408 million in Q2 FY '27 as compared to INR369 million in Q2 FY '26, up by 10.5% year-on-year. EBITDA margin for the quarter stood at 35.5%. A key milestone during Q2 was the commencement of revenue generation from our biologics services. Looking ahead, we expect improvement in CRADS, which is Contract Research and Development Services for large molecules and clinical research during Q3 and Q4. I would request Ms. Harita Vasireddi, Managing Director of Vimta Labs Limited to provide you with the update for the quarter and half year ended 30th September '26. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲10.5% 885.18M INR 210.19M INR '25 Q3 ▲20.6% 944.41M INR 183.19M INR '25 Q4 ▲21.7% 975.64M INR 188.94M INR '26 Q1 ▲22.5% 1.02B INR 199.20M INR '26 Q2 ▲11.4% 986.33M INR 175.86M INR '26 Q3 ▲15.7% 1.09B INR 211.13M INR '26 Q4 ▲11.8% 1.09B INR 210.42M INR '27 Q1 LATEST ▲10% 1.12B INR 206.14M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 380.70 INR Now 498.90 INR · 42% Range high 661.75 INR
vs 200-day avg -5% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Jun 13, 2025; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XNSE:VIMTALABS +0.5% -4.4% +10.5% +2.9% -17.6%

Exchange listing

Market
XNSE
Ticker
VIMTALABS
ISIN
INE579C01029
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.vimta.com/
Investor relations
https://vimta.com/investors/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-06-18 2.00 INR
2025-05-30 1.00 INR
2024-07-11 1.00 INR
2023-06-21 1.00 INR
2022-06-16 1.00 INR
2021-06-25 1.00 INR
2019-07-18 1.00 INR
2018-08-14 1.00 INR
2016-08-25 0.50 INR
2015-08-06 0.50 INR
2014-06-27 1.00 INR
2013-05-23 0.30 INR
2011-09-15 0.20 INR
2010-09-23 0.40 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-30 Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-07-20 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-06 Audio Transcript
    “Vimta Labs Limited Q4 FY '26 Earnings Conference Call”
  • Earnings call · Q3 2026 2026-01-28 Audio Transcript
    Transcript of the Q3-2026 Earnings Investor call- 28.01.2026